226 related articles for article (PubMed ID: 28702798)
1. The Differential Absorption of a Series of P-Glycoprotein Substrates in Isolated Perfused Lungs from Mdr1a/1b Genetic Knockout Mice can be Attributed to Distinct Physico-Chemical Properties: an Insight into Predicting Transporter-Mediated, Pulmonary Specific Disposition.
Price DF; Luscombe CN; Eddershaw PJ; Edwards CD; Gumbleton M
Pharm Res; 2017 Dec; 34(12):2498-2516. PubMed ID: 28702798
[TBL] [Abstract][Full Text] [Related]
2. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: a study in ex vivo lung models using chemical inhibition and genetic knockout.
Al-Jayyoussi G; Price DF; Francombe D; Taylor G; Smith MW; Morris C; Edwards CD; Eddershaw P; Gumbleton M
J Pharm Sci; 2013 Sep; 102(9):3382-94. PubMed ID: 23670704
[TBL] [Abstract][Full Text] [Related]
3. Quantitative prediction of P-glycoprotein-mediated drug-drug interactions and intestinal absorption using humanized mice.
Miyake T; Tsutsui H; Haraya K; Tachibana T; Morimoto K; Takehara S; Ayabe M; Kobayashi K; Kazuki Y
Br J Pharmacol; 2021 Nov; 178(21):4335-4351. PubMed ID: 34232502
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model.
Edwards CD; Luscombe C; Eddershaw P; Hessel EM
Pharm Res; 2016 Nov; 33(11):2604-16. PubMed ID: 27401409
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro.
Tsuruoka S; Sugimoto KI; Fujimura A; Imai M; Asano Y; Muto S
J Am Soc Nephrol; 2001 Jan; 12(1):177-181. PubMed ID: 11134265
[TBL] [Abstract][Full Text] [Related]
6. Estimating Efflux Transporter-Mediated Disposition of Molecules beyond the Rule of Five (bRo5) Using Transporter Gene Knockout Rats.
Miyake T
Biol Pharm Bull; 2020 Mar; 43(3):384-392. PubMed ID: 31685755
[TBL] [Abstract][Full Text] [Related]
7. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.
Dagenais C; Zong J; Ducharme J; Pollack GM
Pharm Res; 2001 Jul; 18(7):957-63. PubMed ID: 11496955
[TBL] [Abstract][Full Text] [Related]
8. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice.
Manford F; Riffo-Vasquez Y; Spina D; Page CP; Hutt AJ; Moore V; Johansson F; Forbes B
J Pharm Pharmacol; 2008 Oct; 60(10):1305-10. PubMed ID: 18812023
[TBL] [Abstract][Full Text] [Related]
9. Influence of P-glycoprotein on pulmonary disposition of the model substrate [
Mairinger S; Hernández-Lozano I; Filip T; Löbsch M; Stanek J; Zeitlinger M; Hacker M; Tournier N; Wanek T; Ehrhardt C; Langer O
Eur J Pharm Sci; 2023 Apr; 183():106404. PubMed ID: 36773747
[TBL] [Abstract][Full Text] [Related]
10. Prediction of nonlinear intestinal absorption of CYP3A4 and P-glycoprotein substrates from their in vitro Km values.
Tachibana T; Kato M; Sugiyama Y
Pharm Res; 2012 Mar; 29(3):651-68. PubMed ID: 21913031
[TBL] [Abstract][Full Text] [Related]
11. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice.
Leusch A; Volz A; Müller G; Wagner A; Sauer A; Greischel A; Roth W
Eur J Pharm Sci; 2002 Aug; 16(3):119-28. PubMed ID: 12128165
[TBL] [Abstract][Full Text] [Related]
12. Kinetic characterization of P-glycoprotein-mediated efflux of rhodamine 6G in the intact rabbit lung.
Roerig DL; Audi SH; Ahlf SB
Drug Metab Dispos; 2004 Sep; 32(9):953-8. PubMed ID: 15319336
[TBL] [Abstract][Full Text] [Related]
13. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
[TBL] [Abstract][Full Text] [Related]
14. PET imaging to assess the impact of P-glycoprotein on pulmonary drug delivery in rats.
Hernández-Lozano I; Mairinger S; Filip T; Sauberer M; Wanek T; Stanek J; Sake JA; Pekar T; Ehrhardt C; Langer O
J Control Release; 2022 Feb; 342():44-52. PubMed ID: 34971693
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C and phosphatidylinositol 3-kinase independently contribute to P-glycoprotein-mediated drug secretion in the mouse proximal tubule.
Tsuruoka S; Sugimoto K; Fujimura A; Imai M; Asano Y; Muto S
Pflugers Arch; 2001 Jun; 442(3):321-8. PubMed ID: 11484761
[TBL] [Abstract][Full Text] [Related]
16. Characterization of P-Glycoprotein Humanized Mice Generated by Chromosome Engineering Technology: Its Utility for Prediction of Drug Distribution to the Brain in Humans.
Yamasaki Y; Kobayashi K; Okuya F; Kajitani N; Kazuki K; Abe S; Takehara S; Ito S; Ogata S; Uemura T; Ohtsuki S; Minegishi G; Akita H; Chiba K; Oshimura M; Kazuki Y
Drug Metab Dispos; 2018 Nov; 46(11):1756-1766. PubMed ID: 29777024
[TBL] [Abstract][Full Text] [Related]
17. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
18. Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein.
Ohashi R; Watanabe R; Esaki T; Taniguchi T; Torimoto-Katori N; Watanabe T; Ogasawara Y; Takahashi T; Tsukimoto M; Mizuguchi K
Mol Pharm; 2019 May; 16(5):1851-1863. PubMed ID: 30933526
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein.
Enright EF; Govindarajan K; Darrer R; MacSharry J; Joyce SA; Gahan CGM
Mol Pharm; 2018 Dec; 15(12):5711-5727. PubMed ID: 30388019
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
